Menu
Recruiting NCT07710625

"Turkish Validity and Reliability of the Heat Sensitivity Scale for Individuals With Parkinson's Disease"

Observational Parkinson Disease Temperature Sensivity

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Parkinson Disease, Temperature Sensivity. Basic parameters: 40 years — 85 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Cross-Cultural Adaptation and Psychometric Evaluation of the Turkish Version of the Heat Sensitivity Scale in Individuals With Parkinson's Disease

Overview

The aim of this study is to examine the validity and reliability of the Turkish version of the Heat Sensitivity Scale in individuals with Parkinson's disease. This cross-sectional methodological study will evaluate the psychometric properties of the scale, including internal consistency, test-retest reliability, and construct validity, in order to provide a valid and reliable tool for assessing temperature sensitivity in Turkish-speaking individuals with Parkinson's disease.

Primary outcome measures

  • Heat Sensitivity Scale Total Score [Time frame: Baseline (at the time of questionnaire administration)]
Secondary outcome measures (1)
  • Parkinson's Disease Questionnaire-39 (PDQ-39) Total and Subscale Scores [Time frame: Baseline (at the time of questionnaire completion)]

Eligibility criteria

Inclusion criteria

  • Clinical diagnosis of Parkinson's disease
  • Hoehn and Yahr stage 1-3
  • Age between 40 and 85 years
  • Mini-Mental State Examination score ≥ 24
  • Sufficient cognitive and communication ability to complete the assessments
  • Attendance at the Movement Disorders Outpatient Clinic of the Neurology Department
  • Willingness to participate and provide written informed consent

Exclusion criteria

  • Presence of a major psychiatric disorder, such as major depressive disorder or a psychotic disorder
  • Diagnosis of advanced dementia
  • Presence of an uncontrolled systemic chronic disease, such as uncontrolled diabetes mellitus or hypertension
  • Presence of a severe cardiovascular or respiratory condition
  • Presence of an additional orthopedic or neurological condition that may affect assessment performance
  • Severe visual or hearing impairment that may interfere with the assessments
  • Inability to cooperate adequately during the assessments

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Turkey (Türkiye) · 1 center
  • Acibadem University — Istanbul

Identifiers

NCT: NCT07710625 · 2026-05-220

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗